Aura Biosciences, Inc. - stock earnings
AURA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -18.5 million USD | ? USD |
| 2023Q2 | -18.3 million USD | ? USD |
| 2023Q1 | -15.2 million USD | ? USD |
| 2022Q4 | -41.8 million USD | ? USD |
| 2022Q3 | -15.7 million USD | ? USD |
| 2022Q2 | -13.1 million USD | ? USD |
| 2022Q1 | -12.9 million USD | ? USD |
| 2021Q4 | -11.6 million USD | ? USD |
| 2021Q3 | -8.8 million USD | ? USD |
| 2021Q2 | -8.9 million USD | ? USD |
| 2021Q1 | -5.9 million USD | ? USD |
| 2020Q4 | -4.9 million USD | ? USD |
| 2020Q3 | -3.6 million USD | ? USD |
AURA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -70.8 million USD | ? USD |
| 2022 | -57.2 million USD | ? USD |
| 2021 | -34.4 million USD | ? USD |
| 2020 | -22.2 million USD | ? USD |
| 2019 | -24.2 million USD | ? USD |
AURA
Price: $7.89
52 week price:
Earnings Per Share: -1.95 USD
P/E Ratio: -4.10
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 120900
Market Capitalization: 380.0 million